KOBE, Japan & BURLINGTON, N.C. -- Sysmex Corporation (TSE:6869) and Laboratory Corporation of America ® Holdings (LabCorp®) (LH:NYSE) today announced a strategic collaboration focused on the ...

PARIS, April 01, 2025 (GLOBE NEWSWIRE) -- Sysmex’s PA-100 AST System is redefining standard of care for diagnosing and treating urinary tract infections (UTIs). By combining cutting-edge nanofluidic ...

HILDEN, Germany & GERMANTOWN, Md. & KOBE, Japan--(BUSINESS WIRE)--QIAGEN (NYSE:QGEN; Frankfurt Prime Standard:QIA) today announced a global strategic alliance with Japan’s Sysmex Corporation (Tokyo ...

MINATO-KU, TOKYO, Japan & KOBE, Japan, February 05, 2026--(BUSINESS WIRE)--Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa; "Fujirebio ...

Basel, 25 January 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that, on 14 December, 2020, it signed a Global Business Partnership Agreement* (GBP) with Sysmex. Under this new framework, ...

TOKYO & KOBE, Japan--(BUSINESS WIRE)--Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa) and Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano) announce that ...

CHICAGO, March 3, 2025 /CNW/ -- Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and informatic solutions, today announced the ...

"Timely hemostasis testing is crucial for diagnosing patients suspected of suffering from bleeding or clotting disorders," said Dan Zortman, CEO of Sysmex America. "Sysmex's CN-Series was designed ...

"Sysmex's hemostasis solutions bring together advanced technology, trusted reagents and award-winning service to provide laboratories with reliable results for diagnosing patients suffering from ...

CHICAGO, Jan. 6, 2025 /CNW/ -- Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and informatics solutions, has signed an ...